文献速递中药与中成药合理使用中医内科

金线草乙酸乙酯提取物通过抑制Skp2/p21信号轴抑制三阴性乳腺癌细胞增殖

Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2/p21 signaling axis.
PubMed 文献 · Phytomedicine · 2023-05-06

本研究探讨金线草乙酸乙酯提取物(AF-EAE)抗三阴性乳腺癌(TNBC)的作用及机制。采用系统药理学、转录组分析、功能实验验证和计算建模相结合的方法,发现AF-EAE在体内外均能抑制TNBC细胞增殖,其机制为抑制Skp2蛋白功能、导致p21积累和CDK6/CCND1蛋白减少,从而将细胞周期阻滞于G1/S期。分子对接和动力学提示槲皮素及其类似物可能结合Skp2蛋白。

要点

  • AF-EAE在体内外均抑制TNBC细胞增殖。
  • AF-EAE通过抑制Skp2功能、上调p21、下调CDK6/CCND1阻滞细胞周期于G1/S期。
  • 槲皮素及其类似物可能是AF-EAE抗TNBC的潜在化学基础。

核心结论

  • AF-EAE通过靶向Skp2/p21信号通路在体内外抑制TNBC生长,为TNBC治疗提供潜在新药。

研究设计与样本

  • 研究采用系统药理学与转录组分析、功能实验验证(细胞活力、细胞周期、移植瘤实验)及计算建模(分子对接、分子动力学)相结合的综合方法。

主要发现

  • RNA-seq分析显示AF-EAE处理后差异表达基因富集于「细胞周期」基因集。
  • AF-EAE在体外和体内均能通过抑制Skp2蛋白功能抑制TNBC细胞增殖。
  • AF-EAE导致p21积累和CDK6/CCND1蛋白减少,使细胞周期停滞于G1/S期。
  • 临床数据生存分析表明Skp2过表达与乳腺癌患者生存率呈负相关。
  • 分子对接和分子动力学提示AF-EAE中的槲皮素及其类似物可能结合Skp2蛋白。

临床怎么用

  • AF-EAE可能作为TNBC治疗的潜在药物,其作用机制涉及Skp2/p21信号轴。
  • Skp2过表达与乳腺癌患者生存率负相关,提示Skp2可作为预后参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Triple negative breast cancer (TNBC) has the worst prognosis of the any breast cancer subtype, and the efficient therapeutical treatment is extremely limited. Antenoron filiforme (Thunb.) Roberty & Vautier (AF) is a Traditional Chinese Medicine (TCM), which is well-known for a diverse array of pharmacological activities, including but not limited to anti-inflammatory, antioxidant and anti-tumors properties. Clinically, AF is commonly prescribed for the treatment of gynecological diseases. PURPOSE: Since TNBC is one of the worst gynecological diseases, the objective of this research is to study the anti-TNBC function of the ethyl acetate extract (EAE) of AF (AF-EAE) and disclose its mechanism of action. MATERIALS AND METHODS: With the aim of elucidating the underlying molecular mechanism and possible chemical basis of AF-EAE in the treatment of TNBC, a comprehensive approach combining system pharmacology and transcriptomic analysis, functional experimental validation, and computational modeling was implemented. Firstly, the potential therapeutic targets of AF-EAE treating TNBC were analyzed by systemic pharmacology and transcriptome sequencing. Subsequently, cell viability assays, cell cycle assays, and transplantation tumor assays were employed to detect the inhibitory effect of AF-EAE on TNBC. Apart from that, the western blot and RT-qPCR assays were adopted to verify its mechanism of action. Finally, the potential chemical basis of anti-TNBC function of AF-EAE was screened through molecular docking and validated by molecular dynamics. RESULTS: This study analyzed the differentially expressed genes after AF-EAE treatment by RNA-sequencing (RNA-seq). It was found that most of the genes were abundant in the gene set termed "cell cycle". Besides, AF-EAE could suppress the proliferation of TNBC cells in vitro and in vivo by inhibiting the function of Skp2 protein. AF-EAE could also lead to the accumulation of p21 and a decrease of CDK6/CCND1 protein, thereby stalling the cycle of cell in the G1/S stage. Notably, clinical data survival analysis clearly demonstrated that Skp2 overexpression has been negatively correlated with survival rates in breast cancer (BC) patients. Further, as suggested by molecular docking and molecular dynamics, the quercetin and its analogues of AF-EAE might bind to Skp2 protein. CONCLUSION: In summary, AF-EAE inhibits the growth of TNBC in vitro and in vivo through targeting Skp2/p21 signaling pathway. While providing a novel potential drug for treating TNBC, this study might establish a method to delve into the action mechanism of TCM.

来源:Phytomedicine,查看原文。版权归原作者所有。

引用

  1. Liao Y, Li S, An J, et al. Ethyl acetate extract of Antenoron Filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing Skp2/p21 signaling axis. Phytomedicine. 2023. PMID: 37187035. doi:10.1016/j.phymed.2023.154856

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。